Domperidone for type 1 diabetes with delayed stomach emptying
Treatments studied
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests whether a medicine called domperidone, which helps the stomach empty faster, can improve blood sugar control in people with type 1 diabetes who have slow stomach emptying. It may help by reducing blood sugar swings and early after-meal lows.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have had type 1 diabetes for more than 5 years and use insulin (via shots or a pump) and a continuous glucose monitor.
- Your blood sugar is not well controlled — time in range is under 60%, or you have high blood sugar swings, or you often have low blood sugar after meals.
- You have few or mild stomach symptoms (like fullness or nausea).
- You are not pregnant or breastfeeding and, if you could become pregnant, you are using an effective birth control method.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether domperidone can help people ages 12–21 with symptoms from stomach not moving well when usual treatments haven’t worked. It’s designed for cases where other causes have been ruled out and patients are monitored for possible heart and hormone side effects.
This program offers domperidone, a medicine that helps the stomach and gut move food along, to cancer patients whose nausea, vomiting, heartburn, or severe constipation has not improved with standard treatments. It aims to relieve these symptoms and improve quality of life.
This study tests a new way to give insulin directly into the abdomen (intraperitoneal) for people with type 1 diabetes. It will check how safe and effective a single dose is over 12 hours, using a special procedure to keep blood sugar stable (clamp).
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This trial tests a medication (called a GLP-1 receptor agonist) to see if it can help people in the earliest stage of type 1 diabetes keep their insulin-making cells working longer. It might help delay the need for insulin injections.
This trial tests whether ondansetron can improve stomach “sensorimotor” problems—how the gut senses food and moves it—especially in people with diabetes and troubling indigestion. It may help reduce symptoms like early fullness, nausea, and discomfort after eating.
Hear when a new Type 1 Diabetic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.